June 2019

• Members of our team drafted a letter to Congress, signed by the 100 leading federal and state disability rights organizations regarding the CDC and FDA corrections and continued harm to pain patients.

• We presented on the dangers of involuntary opioid tapering or discontinuation to the National Academy of Medicine’s Action Collaborative on Countering the U.S. Opioid Epidemic.